Ibogaine and Diphenidol

Moderate caution. Vestibular antimuscarinic antiemetic common in Mexico. QT prolongation and ventricular arrhythmia are reported in overdose; therapeutic-dose cardiac data are thin (grade provisional, physician to confirm). Its labelled hallucinations and confusion compound the ibogaine state. Physician decision only; not first line and not inside the noribogaine peak when another option serves. Lowest labelled dose, QTc on the monitor before the dose and again 1 to 2 h after it; below 460 ms routine, 460 to 499 ms the physician decides, at or above 500 ms or up 60 ms from the stay's baseline no further QT-prolonging antiemetic and the physician is called.

Pre-arrival washout (under your prescribing physician). Discontinuation is completed before arrival, under the patient's own prescribing physician, with the medication-specific washout interval observed before the flood dose. Last dose at least 24 hours before treatment.

QT-interval prolongation. Ibogaine and noribogaine block the cardiac hERG (IKr) potassium channel, which lengthens ventricular repolarisation and the QTc interval on a 12-lead EKG. Adding a second QT-prolonging drug compounds the effect and raises the risk of torsades de pointes, a polymorphic ventricular tachycardia that can be fatal. Every patient receives a baseline EKG, electrolyte panel, and continuous cardiac monitoring; medications in this class must be washed out long enough to return QTc into a safe range.

In many cases yes. Our medical team works with your prescribing physician to taper or substitute medications safely before treatment. The right substitution depends on the underlying condition you are treating with Diphenidol. Contact us for an individual review.